| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Canada | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | China | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | Mexico | 1 | |
| #9 | Russian Federation | 1 | |
| #10 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Levin Olle | 8 |
| #2 | Nilsson Olle | 5 |
| #3 | Fermer Christian | 5 |
| #4 | Ohrvik Anders | 5 |
| #5 | Öhrvik Anders | 3 |
| #6 | Kilmare Eva | 1 |
| #7 | Olle Nilsson | 1 |
| #8 | Strehl Raimund | 1 |
| #9 | Roejer Eva | 1 |
| #10 | Hyllner Johan | 1 |
| Publication | Filing date | Title |
|---|---|---|
| KR20160114716A | Composition and method for detecting malignant neoplastic disease | |
| WO2013038016A2 | Monoclonal antibodies for detection of high-risk human papillomavirus oncoprotein e7 | |
| WO2012060760A1 | Molecular marker for cancer | |
| WO2010037563A1 | Identification of oncofetal antigens using hybridoma libraries raised against human embryonic stem cells | |
| BRPI0606971A2 | site-specific immunization to establish antibodies with specificity for the e7 oncoprotein of high-risk hpvs |